CPHI · China Pharma Holdings, Inc. · Insider Trading
Substantial doubt about the company's ability to continue as a going concern.
“As of June 30, 2026, the Company had cash and cash equivalents of $0.3 million and an accumulated deficit of $49.8 million, and the Company's current liabilities exceeded current assets by $5.7 million. In addition, the Company incurred net losses of $2.6 million and had cash outflows from operating activities of $0.08 million for the six months ended June 30, 2026.”View the 10-Q filed Aug 14, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2023-09-29 | Li Zhilin |
Director, CEO & Interim CFO, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
On September 29, 2023, the reporting person was granted 13,757,063 shares of Issuer's common stock pursuant to certain loan settlement agreement with the Company to settle a loan in the amount of $1,854,452.10 that the Company owed to the reporting person. After giving effect to the 1-for-10 reverse stock split on March 6, 2023, resulting 13,810,000 shares the reporting person previously owned being 1,381,000 shares. |
Common Stock
|
13,757,063 |
| 2021-09-09 | Li Zhilin |
Director, CEO & Interim CFO, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
On September 9, 2021, the reporting person was granted 1,760,000 shares of Issuer's common stock under the Issuer's 2010 Long-Term Incentive Plan, vesting immediately with no restrictions, as partial offset of her accrued but unpaid cash compensation by serving as the Issuer's Chairman of the Board, Chief Executive Officer and interim Chief Financial Officer. |
Common Stock
|
1,760,000 |
| 2020-12-23 | Li Zhilin |
Director, CEO & Interim CFO, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
On December 23, 2020, the reporting person was granted 2,000,000 shares of Issuer's common stock under the Issuer's 2010 Long-Term Incentive Plan, vesting immediately with no restrictions, as partial offset of her accrued but unpaid cash compensation by serving as the Issuer's Chairman of the Board, Chief Executive Officer and interim Chief Financial Officer. |
Common Stock
|
2,000,000 |